会社情報, 微生物ゲノム

Illumina statement on novel coronavirus

Illumina has enacted precautionary measures focusing on the health and safety of our employees, families, customers and communities

Illumina statement on novel coronavirus
2020年3月17日

With the global spread of SARS-CoV-2, Illumina has enacted precautionary measures focusing on the health and safety of our employees, families, customers and communities. To help protect Illumina employees and business continuity, we have proactively implemented efforts including limiting travel and attendance at meetings and conferences, and allowing employees to work remotely, where possible. We are closely monitoring the situation and will update our action plan to protect employees, keep customers running and support efforts to minimize the spread of the virus. To date, we have not experienced sustained supply chain or other operational delays. We will continue to monitor and update as the situation evolves, balancing the safety of our employees and the needs of our customers. 

 

 

Recent Articles

Greenwood Genetic Center: Answering the unanswered
Greenwood Genetic Center: Answering the unanswered
Can genomics stop the world’s leading cause of death?
Can genomics stop the world’s leading cause of death?
Breeding a more resilient yam in West Africa
Breeding a more resilient yam in West Africa